Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

RemedyRepack Inc.: Lisinopril/HCTZ Tablets Recalled for Presence of Foreign Medication

Agency Publication Date: March 16, 2020
Share:
Sign in to monitor this recall

Summary

RemedyRepack Inc. has recalled about 480 tablets of Lisinopril/HCTZ (20mg/12.5mg), a medication used to treat high blood pressure. The recall was initiated because a different medication, a Lupin Fenofibrate 145mg tablet used for cholesterol, was found inside a bottle of Lisinopril/HCTZ. This mix-up could lead to consumers accidentally taking the wrong medication, which may result in unexpected side effects or uncontrolled blood pressure. These products were distributed in Pennsylvania and packaged in blister cards of 30 tablets each.

Risk

Taking an incorrect medication like Fenofibrate instead of the prescribed Lisinopril/HCTZ can cause serious health complications, including allergic reactions, adverse drug interactions, or a lack of treatment for the patient's actual condition.

What You Should Do

  1. Check your medication packaging for Lisinopril/HCTZ 20mg/12.5mg tablets in 30-count blister cards with Lot # J0322819-091418 and an expiration date of 09/30/2019.
  2. Identify the affected product by looking for NDC 70518-0382-03 on the repackaged blister cards or NDC 68180-0519-02, which was the original code on the source 500-count bottles.
  3. If you have this specific lot, stop taking the medication immediately and inspect the tablets for any foreign or unusual-looking pills that do not match the rest of the pack.
  4. Contact your healthcare provider or pharmacist immediately for guidance on obtaining a replacement prescription and to report if you have accidentally consumed a foreign tablet.
  5. Return any remaining unused medication to the pharmacy where it was purchased for a refund and further instructions.
  6. Contact RemedyRepack Inc. at their facility in Indiana, PA for more information regarding this recall.
  7. For additional questions or to report a complaint, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Contact healthcare provider and return product for refund.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Lisinopril/HCTZ 20mg/12.5mg Tablet (30 tablets per blister card)
Model:
NDC 68180-0519-02
NDC 70518-0382-03
Lot Numbers:
J0322819-091418 (Exp: 09/30/2019)
Date Ranges: 09/30/2019

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 83645
Status: Resolved
Manufacturer: RemedyRepack Inc.
Manufactured In: United States
Units Affected: 480 tablets
Distributed To: Pennsylvania

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.